SweBioFertil: Impact of the Microbiome on Time to Pregnancy and Pregnancy Outcomes in Fertile Women Attempting to Conceive

Sponsor
Karolinska Institutet (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05127252
Collaborator
Karolinska University Hospital (Other)
500
1
35.6
14

Study Details

Study Description

Brief Summary

This study aims to investigate the microbiome of women with previously proven fertility who plan to become pregnant.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Vaginal and rectal microbiome and metabolome

Detailed Description

The women will be recruited at the time of removal of a copper or hormonal intrauterine device (IUD) or removal of a contraceptive implant at the barnmorskemottagningar (midwife clinics) in Stockholm's county in Sweden. A total of 500 women will be included in the study and will be followed until conception or up to the end of 1 year, whichever comes first. If conception occurs, the woman will be followed throughout pregnancy. Participant recruitment will take place over a period of two years.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
500 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Impact of the Microbiome on Time to Pregnancy and Pregnancy Outcomes in Fertile Women Attempting to Conceive
Anticipated Study Start Date :
Jan 10, 2022
Anticipated Primary Completion Date :
Dec 30, 2024
Anticipated Study Completion Date :
Dec 30, 2024

Outcome Measures

Primary Outcome Measures

  1. The microbiome profile and metabolome associated with time to pregnancy, miscarriage, and live birth will be assessed. [2024]

Secondary Outcome Measures

  1. Microbiome profiles and metabolome related to obstetric outcomes [2024]

  2. The microbiome profile for women above age >38 and women below <38. [2024]

  3. The influence of BMI, medications and comorbidities on the microbiome profiles. [2024]

  4. Microbiome profile for those women who don't conceive within a year. [2024]

  5. The metabolome of the recognized microbiome for women with normal pregnancy outcomes [2024]

  6. The metabolome of the recognized microbiome for women who develop miscarriage or other pregnancy complications [2024]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Women with a previous live birth in the past 5 years and planning a new pregnancy with the same male partner.

  • 18-40 years of age

  • Swedish personal identity number and a Swedish address (to send a sampling self-kit)

  • Sufficient understanding of spoken and written Swedish or English to provide informed consent and complete the web-based questionnaire.

Exclusion Criteria:
  • Women who do not have a child yet and plan to cease their contraception.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Reproductive Medicine, Karolinska University Hospital Stockholm Huddinge Sweden 141 57

Sponsors and Collaborators

  • Karolinska Institutet
  • Karolinska University Hospital

Investigators

  • Study Chair: Lars Holmgren, Professor, Karolinska Institutet

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kenny Rodriguez-Wallberg, MD, PhD, Professor, Karolinska Institutet
ClinicalTrials.gov Identifier:
NCT05127252
Other Study ID Numbers:
  • Dnr 2021-03765
First Posted:
Nov 19, 2021
Last Update Posted:
Nov 19, 2021
Last Verified:
Nov 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Kenny Rodriguez-Wallberg, MD, PhD, Professor, Karolinska Institutet
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 19, 2021